about
Extracellular Release and Signaling by Heat Shock Protein 27: Role in Modifying Vascular InflammationUpdate on the role of alternatively activated macrophages in asthmaCD40 in coronary artery disease: a matter of macrophages?The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human DiseasesMacrophage-mediated cholesterol handling in atherosclerosisMacrophage Heterogeneity and Plasticity: Impact of Macrophage Biomarkers on AtherosclerosisInflammation in arterial diseasesGenetic and genomic approaches to understanding macrophage identity and functionMinireview: Emerging Concepts in Islet Macrophage Biology in Type 2 DiabetesOncostatin M receptor β deficiency attenuates atherogenesis by inhibiting JAK2/STAT3 signaling in macrophages.M2 macrophage is the predominant phenotype in airways inflammatory lesions in patients with granulomatosis with polyangiitisMacrophage Apoptosis and Efferocytosis in the Pathogenesis of AtherosclerosisRecent developments in vascular biologySex differences in inflammation during atherosclerosis.Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms.OGR1/GPR68 Modulates the Severity of Experimental Autoimmune Encephalomyelitis and Regulates Nitric Oxide Production by Macrophages.Macrophage Differentiation from Monocytes Is Influenced by the Lipid Oxidation Degree of Low Density Lipoprotein.MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout MiceCytokines: roles in atherosclerosis disease progression and potential therapeutic targetsCXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis.Vitamin D Protects Against Atherosclerosis via Regulation of Cholesterol Efflux and Macrophage Polarization in Hypercholesterolemic Swine.CD16+ Monocytes and Skewed Macrophage Polarization toward M2 Type Hallmark Heart Transplant Acute Cellular Rejection.An agent-based model of leukocyte transendothelial migration during atherogenesis.TREM-1 links dyslipidemia to inflammation and lipid deposition in atherosclerosis.Macrophages and immune cells in atherosclerosis: recent advances and novel concepts.The role of complement activation in atherogenesis: the first 40 years.Nanoparticle uptake by macrophages in vulnerable plaques for atherosclerosis diagnosis.Similarities in the Metabolic Reprogramming of Immune System and EndotheliumSex Differences in Vascular Physiology and Pathophysiology: Estrogen and Androgen Signaling in Health and Disease.The Role of Decidual Macrophages During Normal and Pathological Pregnancy.Atherogenesis: hyperhomocysteinemia interactions with LDL, macrophage function, paraoxonase 1, and exercise.Geraniin Inhibits LPS-Induced THP-1 Macrophages Switching to M1 Phenotype via SOCS1/NF-κB Pathway.Delta-Like Ligand 4-Notch Signaling in Macrophage Activation.Macrophages in vascular inflammation and atherosclerosis.Transcriptome-Wide Analysis Reveals Modulation of Human Macrophage Inflammatory Phenotype Through Alternative Splicing.Among human macrophages polarised to different phenotypes, the M-CSF-oriented cells present the highest pro-inflammatory response to the rheumatoid arthritis-specific immune complexes containing ACPA.Proinflammatory M1 Macrophages Inhibit RANKL-Induced Osteoclastogenesis.Epigenetics and trained immunity.Puerarin Inhibits oxLDL-Induced Macrophage Activation and Foam Cell Formation in Human THP1 Macrophage.Fibroblast growth factor 21 potentially inhibits microRNA-33 expression to affect macrophage actions
P2860
Q26738276-6FB75FF0-38CE-4552-B0FC-3312454CDDF0Q26746898-89E7D910-2165-4B4A-B7CC-151E6B261912Q26752784-1ECE0DE6-4858-47DF-9AA8-488565522AB4Q26752888-EA3BFF2B-785C-4CC3-A02D-2B73AA381F18Q26780405-25574E8E-9562-42DC-8A34-87534DAFF08CQ26780531-97EA744D-82B6-484E-97F2-06637A1D5F80Q26853576-71652BBA-985D-48D6-B424-6035941A2107Q27004261-5CD0BBC8-50EA-4C73-BAF1-FF8B96E94843Q28083768-08EDF410-6CC5-4D6D-AC32-6695D0BF057CQ33613358-3221E32C-B29F-449C-9C18-44F228BF74C7Q33706866-CA1C6F9A-BF6E-448A-9462-CB802D42A3F6Q33764821-081BDAB4-106D-4163-A040-3A94DA3D6159Q34662445-A17C0118-F9B3-49EB-A8CF-7C1D6F249064Q35509492-5E41820C-1308-4865-8186-316F39FC27EBQ35674290-3037A339-B5CC-4BCC-9A81-00BC487F94FFQ35909620-5375F199-EE98-4595-8CAE-38304AA8717DQ35941872-047D99D5-571C-4C75-83F4-11BB2112FB11Q36039213-EFA6E179-67FA-4C9C-8493-BF8986692D9AQ36064353-BDFDB01E-B842-431F-AEBF-DD936482252CQ36187349-178B91B8-977F-45BE-B47F-F1FE0B901D3CQ36201821-6E8A8466-0468-4084-B5A2-229FD1327D46Q36341489-10D5BE55-B1E4-41AC-8DAD-C5CC981B4558Q36380070-5225552B-D30A-4EAF-A86E-A9F51575D591Q37366497-A24439DA-977F-4F98-AEAB-6D389FE8D013Q38462573-6111B4D8-E1CE-4A96-9BD5-8C61FD982303Q38532361-9181107A-6FD7-40E9-B6EE-B3359943F056Q38537648-1BB30B8E-E432-4A86-B69A-436E07CA3CC5Q38645730-B411ADAD-C1F1-47F3-B634-BF534534F476Q38669622-B6A7EB4E-8F52-4AC1-8736-05D15FFEB4D0Q38691715-CFD9BD44-B051-42DC-85BD-7F87AFE97804Q38724228-4984414B-3A4F-4503-A61F-562227CB8DBBQ38764936-597E0ADD-8017-477F-AA49-E655EE7B0D7DQ38937592-757A975F-168A-4E78-9633-4E8CCBB73462Q39123553-41D7AC5C-61F3-4A57-B8DF-15427A61A32EQ39733187-5B45F567-006C-4F80-B4F5-28ADB94FCB37Q39892607-66CB29E9-9828-4699-9EAC-CB9D58E6AF7BQ41193254-D3700291-3CA7-4881-BEC8-1E48B18416C2Q41991194-9E076CC3-6585-4E1B-9C8B-7F39E766163AQ42096576-05FF1D71-403A-486F-8CE3-893D38F20CBAQ42359780-DB53E520-6BCB-40C1-8FA6-FFF255A97A57
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Macrophage phenotypes in atherosclerosis.
@en
type
label
Macrophage phenotypes in atherosclerosis.
@en
prefLabel
Macrophage phenotypes in atherosclerosis.
@en
P2860
P356
P1476
Macrophage phenotypes in atherosclerosis
@en
P2093
Sophie Colin
P2860
P304
P356
10.1111/IMR.12218
P577
2014-11-01T00:00:00Z